Neuroscale AI, a provider of secure, agentic artificial intelligence solutions, announced today it has been awarded a $540,000 Small Business Innovation Research (SBIR) Phase II contract by the U.S.

As healthcare systems advance precision diagnostics and risk stratification, integrating Cystatin C into routine practice is increasingly important. A measure of kidney function, Cystatin C ...

Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a pre-clinical-stage biotechnology company developing intranasal administrated solutions, today announced the signing of an agreement with ...

Science Corp secures $230M funding to accelerate its brain-computer interface technology and retinal implant designed to restore vision ...

CEO Sanjay Shukla outlined the company’s strategy to develop new therapies for inflammation and fibrosis based on tRNA synthetase biology during a presentation at the Leerink Partners Global ...

OESC CEO Trae Rahill, attending the NGA's Winter Workforce Policy Institute, discusses efforts to take workforce development ...

Kevin Walton, Baseimmune CEO. IPF is a progressive and life-threatening condition marked by aberrant wound healing, ...

C reiterated its strategic priorities and financial targets, highlighting strong growth opportunities despite persistent ...

NUAIR and the Syracuse Regional Airport Authority (SRAA) today celebrated the selection of the Port Authority of New York and New Jersey (PANYNJ) as one of eight projects nationwide chosen to ...

The state has won a key federal approval for its plan to award nearly $630 million to more than a dozen companies to help modernize internet service in Alaska.

Switch from manual entries to automated generators that keep your spreadsheets clean, consistent, and error-free.